GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

NCT03029351 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped termination by sponsor

Conditions

Type2 Diabetes
Kidney Diseases

Interventions

DRUG: Exenatide Extended Release for Inj Susp 2 MG
DRUG: Placebo

Sponsor

University at Buffalo

Collaborators

[object Object]